Page 5 - Jon Nugent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jon nugent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jon Nugent Today - Breaking & Trending Today

'Brisk' footfall as retail fully reopens with shopping centres busier than city streets


 
Retailers reported brisk footfall levels as the sector fully reopened on Monday, with Dundrum Town Centre saying that the number of shoppers breached pre-pandemic levels during the afternoon.
“I was expecting footfall to be down on normal,”said Don Nugent, the centre’s director. “But when we measured footfall at 3pm, it was 11 per cent ahead of where it was at the same time, on the same day in 2019.”
Speaking in the late afternoon, he said he was expecting the centre to be “quite busy” in the evening with most retailers trading late, although some were closing earlier due to staffing issues. ....

South Tipperary , Duncan Graham , Marks Spencer , Dundrum Town Centre , Dublin Town , Henry Street , Grafton Street , Retail Ireland , Arnold Dillon , Jon Nugent , Graham Duncan , Richard Guiney , Irish Business And Employers Confederation , Marks And Spencer , Retail Excellence , Tk Maxx , தெற்கு உதவிக்குறிப்பு , டங்கன் கிரஹாம் , மதிப்பெண்கள் ஸ்பென்சர் , டப்ளின் நகரம் , ஹென்றி தெரு , கிராப்டன் தெரு , சில்லறை ஐயர்ல்யாஂட் ,

UAB spinoff receives $3 million in seed funding to develop probiotic formulations for lung health


UAB spinoff receives $3 million in seed funding to develop probiotic formulations for lung health
A biomedical research company founded by a University of Alabama at Birmingham physician-scientist has received $3 million in seed funding.
ResBiotic Inc. spun off from UAB last year will use the money to develop and commercialize groundbreaking probiotic formulations for lung health, says founder C. Vivek Lal, M.D., an associate professor in the UAB Department of Pediatrics, Division of Neonatology. The seed round was funded from a private equity syndicate led by Birmingham-based investment firm Timberline Holdings.
ResBiotic s first product aims to supplement the nutritional needs in chronic lung diseases. The product was developed in Lal s Pulmonary Microbiome Lab at UAB, with research and expertise from UAB s Microbiome Center, Lung Health Center, and the Translational Research in Normal & Disordered Development program. ....

Namasivayam Ambalavanan , Andrew Oconnor , C Vivek Lal , Jon Nugent , Braxton Goodrich , Emily Henderson , Scott Bush , Amit Gaggar , Sanjay Singh , Microbiome Center , Birmingham Business Alliance , Resbiotic Inc , Division Of Neonatology , Lal Pulmonary Microbiome Lab , Resbiotech Innovation Institute , University Of Alabama At Birmingham , Timberline Holdings , Department Of Cell , Division Of Pulmonary , Translational Research In Normal Disordered Development , Department Of Pediatrics , Department Of Medicine , Lung Health Center , Pulmonary Microbiome Lab , Translational Research , Disordered Development ,

UAB spinoff to treat chronic respiratory disease announces $3 million seed funding


Credit: UAB
BIRMINGHAM, Ala. - A biomedical research company founded by a University of Alabama at Birmingham physician-scientist has received $3 million in seed funding.
ResBiotic Inc. spun off from UAB last year will use the money to develop and commercialize groundbreaking probiotic formulations for lung health, says founder C. Vivek Lal, M.D., an associate professor in the UAB Department of Pediatrics, Division of Neonatology. The seed round was funded from a private equity syndicate led by Birmingham-based investment firm Timberline Holdings.
ResBiotic s first product aims to supplement the nutritional needs in chronic lung diseases. The product was developed in Lal s Pulmonary Microbiome Lab at UAB, with research and expertise from UAB s Microbiome Center, Lung Health Center, and the Translational Research in Normal & Disordered Development program. ....

Namasivayam Ambalavanan , Andrew Oconnor , C Vivek Lal , Jon Nugent , Braxton Goodrich , Scott Bush , Amit Gaggar , Sanjay Singh , Microbiome Center , Resbiotic Inc , Division Of Neonatology , Lal Pulmonary Microbiome Lab , Innovation For The Birmingham Business Alliance , Resbiotech Innovation Institute , University Of Alabama At Birmingham , Timberline Holdings , Department Of Cell , Division Of Pulmonary , Translational Research In Normal Disordered Development , Department Of Pediatrics , Department Of Medicine , Lung Health Center , Pulmonary Microbiome Lab , Translational Research , Disordered Development , Innovation Depot ,

ResBiotic, Inc. Raises $3M Seed Round and Announces Leadership Team


Share this article
Share this article
BIRMINGHAM, Ala., April 29, 2021 /PRNewswire/ University of Alabama at Birmingham s biotech startup Resbiotic, Inc. today announced a $3M seed round to support the development and commercialization of groundbreaking probiotic formulations for lung health. The round was funded from a private equity syndicate led by Timberline Holdings.  
ResBiotic is the flagship company of ResBiotech Innovation Institute, founded by physician scientist Dr. C Vivek Lal in 2020. ResBiotic s first product, a medical food that targets the gut-lung axis, was developed in Dr. Lal s Pulmonary Microbiome Lab at UAB with research and expertise from the university s Microbiome Center, Lung Health Center and Translational Research in Normal & Disordered Development (TReNDD) program. The proprietary probiotic blend has been shown to reduce neutrophilic inflammation in individuals with chronic respiratory conditions. The company s research and developmen ....

United States , University Of Alabama At Birmingham , Namasivayam Ambalavanan , Andrew Oconnor , Scott Bush , Amit Gaggar , C Vivek Lal , Jon Nugent , Sanjay Singh , Prnewswire University , Microbiome Center , Resbiotic Inc , Innovation For The Birmingham Business Alliance , Lal Pulmonary Microbiome Lab , Resbiotech Innovation Institute , Timberline Holdings , Braxton Goodrich Timberline Holdings , Translational Research In Normal Disordered Development Tre , Harvard University , Lung Health Center , Pulmonary Microbiome Lab , Translational Research , Disordered Development , Chief Scientific Officer , Braxton Goodrich , Resbiotic Board ,